Catalent’s Indiana plant to make Novo’s Wegovy weight-loss drug 



Reuters exclusively reported that Novo Nordisk has hired Thermo Fisher as its second contract manufacturer for its hugely popular weight-loss drug Wegovy. Novo Chief Financial Officer Karsten Munk Knudsen told Reuters in May the company had signed up a second contract manufacturer in the United States, but the identity of the company has not previously been reported. This was followed by another exclusive that Catalent’s plant in Bloomington, Indiana, will fill injection pens for Novo Nordisk’s  Wegovy as part of the two companies’ expanded supply agreement. Catalent’s shares briefly jumped on the news. 

Market Impact

Shares in Thermo jumped as much as 4% during New York trading on Wednesday. 

Article Tags

Topics of Interest: Health

Type: Reuters Best

Sectors: Pharmaceuticals & Healthcare

Regions: Americas

Countries: United States

Win Types: Exclusivity

Story Types: Exclusive / Scoop

Media Types: Text

Customer Impact: Significant National Story


Source link

Related articles

CDC probes charcuterie sampler sold at Sam’s Club in salmonella outbreak

[ad_1] Federal safety officials are investigating whether recalled meat samplers sold at Sam’s Club warehouses across the country are involved in an outbreak of salmonella that has stricken two dozen people in 14 states. The U.S. Centers for Disease Control and Prevention on Friday posted a food safety alert cautioning consumers about Busseto Foods brand […]

Even Rats Are Taking Selfies Now (and Enjoying It)

[ad_1] When Augustin Lignier, a professional photographer in Paris, was in graduate school, he began to ponder the point of picture-taking in the modern world: Why did so many of us feel compelled to photograph our lives and share those images online? It was not a novel question, but it led Mr. Lignier to a […]

Leave a Reply

Your email address will not be published. Required fields are marked *